English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

From the early roots of modern urology to today, genitourinary (GU) cancers have been an important part of the fields of urology and cancer biology. As medical science has advanced, newer clinical and basic viewpoints have impacted the thinking and practice in this important field. As such, GU oncology has been consistently seen as an area of rapid evolution both in biological understanding and clinical care. GU cancers continue to rise in incidence worldwide. Moreover, they represent a significant portion of cancer mortality in Asia and the western world. These facts have been met with some of the boldest and most important advances in cancer biology and therapy that have reshaped this field.

Biology and therapy of urological cancer metastasis